The biotech start-up Ribbon Biolabs is developing a high-throughput method for the production of extremely long DNA strands that can be automated for the first time. This will take biotechnology to a new level in application areas such as biopharmaceuticals, biomedicine, biofuels, nanotechnology and bioinformatics and open up completely new possibilities
